(Q43425405)

23 November 2017

Immune responses to dystropin: implications for gene therapy of Duchenne muscular dystrophy (English)

1 reference

23 November 2017

0 references

Ferrer A

1

1 reference

23 November 2017

Wells KE

series ordinal

2

1 reference

23 November 2017

Wells DJ

series ordinal

3

1 reference

23 November 2017

1 September 2000

1 reference

23 November 2017

1 reference

23 November 2017

7

1 reference

23 November 2017

17

1 reference

23 November 2017

1439-1446

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301259

23 November 2017

0 references

cites work

Very mild muscular dystrophy associated with the deletion of 46% of dystrophin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Duchenne muscular dystrophy gene product is not identical in muscle and brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

The membrane-cytoskeleton interface: the role of dystrophin and utrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

X chromosome-linked muscular dystrophy (mdx) in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Somatic reversion/suppression of the mouse mdx phenotype in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Immune responses, not promoter inactivation, are responsible for decreased long-term expression following plasmid gene transfer into skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Evaluation of plasmid DNA for in vivo gene therapy: factors affecting the number of transfected fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

The immunobiology of muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Quantitative estimation of dystrophin protein: a sensitive and convenient "two-antibody sandwich" ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

7 January 2021

Serum antibodies to the deleted dystrophin sequence after cardiac transplantation in a patient with Becker's muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

7 January 2021

Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

7 January 2021

Coisogenic all-plus-one immunization: a model for identifying missing proteins in null-mutant conditions. Antibodies to dystrophin in mdx mouse after transplantation of muscle from normal coisogenic donor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

7 January 2021

The molecular basis of muscular dystrophy in the mdx mouse: a point mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

7 January 2021

Dystrophin gene transcripts skipping the mdx mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

7 January 2021

Is myoblast transplantation effective?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

7 January 2021

Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

7 January 2021

Dystrophin in skeletal muscle. I. Western blot analysis using a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301259

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301259

1 reference

Dimensions Publication ID

23 November 2017

0 references

1 reference